Facilitated By

San Antonio Medical Foundation

News

  • BioNTech's overall survival data show promise of potential Keytruda killer in breast cancer

    The German biotech ... Researchers shared the first look at OS data from the Chinese trial at the San Antonio Breast Cancer Symposium Tuesday.

  • ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with ... - Morningstar

    Data from Phase 1b/2 clinical trial to be presented at 2024 San Antonio Breast Cancer Symposium (SABCS) show encouraging clinical activity in ...

  • Bio-Techne Corp (TECH) Launches Innovative ESR1 Mutation Monitoring Assay

    The assay will be featured at the San Antonio Breast Cancer Symposium, offering a highly sensitive detection method using qPCR technology. This ...

  • UTSA's Stanton F. McHardy named fellow of National Academy of Inventors | UTSA Today

    The CIDD is a collaborative initiative between UTSA and UT Health San Antonio. “I feel extremely honored to be included as an NAI fellow and have the ...

  • Richmond-based BioAge sees stock fall over 70% after halting obesity drug clinical trial

    San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Bay Area biotech sells cancer drug for over $400 million. Related ...